Navigation Links
NIAID set to launch clinical trials to test 2009 H1N1 influenza vaccine candidates
Date:7/22/2009

erly volunteers who are given the seasonal flu vaccine along with a 15 microgram dose of 2009 H1N1 vaccine. The H1N1 vaccine would be given to different sets of volunteers either before, after, or at the same time as the seasonal flu vaccine. If early information from those studies indicates that these vaccines are safe, similar trials in healthy children (aged 6 months to 17 years old) will start.

A panel of outside experts will conduct a close review of the safety data from these trials to spot any safety concerns in real time. Information from these studies in healthy people will help public health officials develop recommendations for immunization schedules, including the optimal dosage and number of doses for multiple age groups, including adults, the elderly, and children. Data may also be used to support decisions about the best recommendations for people in high risk groups, including pregnant women and people whose immune systems are weakened or otherwise compromised.

The trials are being conducted in a compressed timeframe in a race against the possible autumn resurgence of 2009 H1N1 flu infections that may occur at the same time as seasonal influenza virus strains begin to circulate widely in the Northern Hemisphere.

Close collaboration among NIAID, the U.S. Food and Drug Administration (FDA) and the Biomedical Advanced Research and Development Authority (a component of the Department of Health and Human Services) was key to launching the trials quickly while ensuring high standards. Following initial discussions between the agencies on trial design, NIAID prepared the protocols and submitted them to the FDA for review. FDA rapidly completed the necessary reviews and approved the trial protocols.

Since 1962, NIAID's Vaccine and Treatment Evaluation Units (VTEUs) have been intensively involved in the successful development and clinical testing of vaccines and treatments against many pathogens that threaten the health
'/>"/>

Contact: Anne A. Oplinger
niaidnews@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. NIAID media availability: New strategy proposed for designing antibody-based HIV vaccine
2. J. Craig Venter Institute Awarded $43 Million, Five Year Contract From NIAID to Continue to Develop and Provide Sequencing, Genotyping, and Bioinformatics Expertise and Services in Infectious Diseases
3. NIAID and Chinese officials sign agreement to foster TB research in Chinas Henan province
4. NIAID honors AIDS activist Martin Delaney
5. NIAID media availability: Seizures following parasitic infection associated with brain swelling
6. NIAID awards contracts to search for protein markers of disease
7. NIAID creates HIV vaccine discovery branch
8. NIAID to advance B-cell approach to HIV vaccines
9. NIAID describes research priorities to fight drug-resistant tuberculosis
10. NIAID to convene HIV Vaccine Summit
11. NIAID scientists identify new cellular receptor for HIV
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... 2015 METTLER TOLEDO has announced ... Data Integrity in a GXP Regulated Laboratory ", ... This webinar will be presented on May 27, ... integrity is a critical component of pharmaceutical product ... However, in recent years an increasing number of ...
(Date:5/4/2015)... NORTH HOLLYWOOD, Calif. (PRWEB) May 04, 2015 ... awards program recognizes IPC clinical leaders who have made ... to the patients they serve, both in acute and ... Hospitalist of the Year, Post-Acute Provider of the Year, ... the Year and Specialist Provider of the Year. Recipients ...
(Date:5/4/2015)... EY today announced that Kevin MacDonald, CEO and ... EY Entrepreneur Of The Year® 2015 Award in the ... who demonstrate excellence and extraordinary success in such areas ... businesses and communities. Mr. MacDonald was selected as ... Award winners will be announced on Thursday, June 18, ...
(Date:5/4/2015)... Los Angeles dental implants ... comfortable and attractive alternative for patients with dentures. Dentures ... who have lost teeth. Unfortunately, they also require some ... at the worst possible moment and may make clicking ... also painfully pinch or rub gums, leaving sores and ...
(Date:5/4/2015)... May 04, 2015 Ticket Down is a ... Colonial Life Arena in Columbia, South Carolina. Fans ... of his “Out There” tour which originally kicked off in ... is North America and the legendary performer recently announced that ... Wells Fargo Arena on June 21st, in Charlottesville, VA at ...
Breaking Medicine News(10 mins):Health News:METTLER TOLEDO Announces Live Webinar on the Importance of Data Integrity in a GXP Regulated Laboratory 2Health News:IPC Healthcare Announces Clinicians of the Year 2Health News:IPC Healthcare Announces Clinicians of the Year 3Health News:EY announces Kit Check CEO and Co-founder Kevin MacDonald as an EY Entrepreneur Of The Year® 2015 Award finalist in the Greater Washington Region 2Health News:Los Angeles Dental Implants Doctor, Kevin Sands DDS, Now Offers a More Comfortable and Aesthetically-Pleasing Solution to Denture-Wearers 2Health News:Paul McCartney Tickets at Colonial Life Arena in Columbia, SC: Ticket Down Slashes Paul McCartney Ticket Prices in Columbia, South Carolina at Colonial Life Arena 2
... Jenifer Goodwin HealthDay Reporter , THURSDAY, Sept. 8 ... first-grade class when the hijacked planes with their terrified passengers ... that day are incomplete, they,re burned into her memory just ... seeing her mother glued to the TV, watching the Twin ...
... In light of a national survey showing that only about ... a compassionate one, the Schwartz Center for Compassionate Healthcare today ... in the September issue of Health Affairs , the ... compassionate care matters because it is fundamental to the practice ...
... broad panel of leaders representing health care, academic medicine, ... the content and format of U.S. graduate medical education ... and efficiently to meet public needs. The ... overhauling the training of newly minted physicians - "residents" ...
... for a second stroke who received intensive medical treatment had ... stent in addition to the medical treatment, a large nationwide ... online first edition of the New England Journal of ... of the clinical research sites for the study. ...
... , THURSDAY, Sept. 8 (HealthDay News) -- The bigger ... RAND Corp. study finds. The researchers found a roughly ... fewest health plans. The reason for this decline, they said, ... lower prices from health providers. This consolidation, the study concluded, ...
... 8, 2011The number of underinsured adultsthose with health insurance all ... their incomesrose by 80 percent between 2003-2010, from 16 million ... published in the September issue of Health Affairs. Nearly half ... in 2010, up from 75 million in 2007 and 61 ...
Cached Medicine News:Health News:9/11 a Life-Defining Day for the Young 2Health News:9/11 a Life-Defining Day for the Young 3Health News:9/11 a Life-Defining Day for the Young 4Health News:Schwartz Center proposes agenda to promote compassionate care 2Health News:Schwartz Center proposes agenda to promote compassionate care 3Health News:Macy Foundation report calls for sweeping graduate medical education reforms 2Health News:Macy Foundation report calls for sweeping graduate medical education reforms 3Health News:Macy Foundation report calls for sweeping graduate medical education reforms 4Health News:Stroke prevention trial finds intensive medical treatment has better results than brain stenting 2Health News:Stroke prevention trial finds intensive medical treatment has better results than brain stenting 3Health News:Big Health Plans Can Negotiate Lower Hospital Costs: Study 2Health News:Insured and still at risk: Number of underinsured increased 80 percent between 2003 - 2010 2Health News:Insured and still at risk: Number of underinsured increased 80 percent between 2003 - 2010 3
(Date:5/4/2015)... 2015 Rogne Bioscience, a privately-held biotechnology company ... preclinical and mechanism of action data will be presented ... Dermatology (SID) Annual Meeting being held May 6-9, 2015 ... . Logo - http://photos.prnewswire.com/prnh/20150501/213318LOGO ... a novel, low MW (<1700 daltons) peptide as a ...
(Date:5/4/2015)... , May 4, 2015 Bayer HealthCare (Bayer) ... Pharmaceuticals, Inc. (NASDAQ: ISIS ) on ISIS-FXI Rx, ... the prevention of thrombosis. Under the agreement Bayer will ... of high unmet medical need. As part of the ... profile of ISIS-FXI Rx in an appropriate patient ...
(Date:5/4/2015)...  Clinical Support Services, Inc. (CSS) Resident Pharmacist, ... analysis of Pharmacologic Adverse Events in patients with ... Services, Inc. clinical staff were used to conduct ... psychiatric medications to assess the frequency of adverse ... patients experienced at least one ADE and 87% ...
Breaking Medicine Technology:Rogne Bioscience to Present Data from Topical Biologic Psoriasis Program at Upcoming SID Annual Meeting 2015 2Bayer Licenses Investigational ISIS FXI(Rx) from Isis Pharmaceuticals to Develop and Commercialize for the Prevention of Thrombosis 2Bayer Licenses Investigational ISIS FXI(Rx) from Isis Pharmaceuticals to Develop and Commercialize for the Prevention of Thrombosis 3Clinical Support Services, Inc. Verifies That Increased Availability of MTM Services Facilitates Identification of Adverse Drug Effects in Psychiatric Patients 2Clinical Support Services, Inc. Verifies That Increased Availability of MTM Services Facilitates Identification of Adverse Drug Effects in Psychiatric Patients 3
... Oct. 19 Mylan Inc. (Nasdaq: MYL ) ... stock issuance, the company has declared its quarterly dividend of ... 6.5% and a liquidation preference of $1,000.00 per share) payable ... record as of Nov. 1, 2010.  Nov. 15, is also ...
... Oct. 19 Reportlinker.com announces that a new ... Renal Cell Carcimona Cancer Drug ... AN EXCEPTIONALLY COST EFFECTIVE SERVICE INCLUDING ... Espicom,s Renal Cell Carcinoma Cancer Drug Futures includes ...
Cached Medicine Technology:Reportlinker Adds Renal Cell Carcimona Cancer Drug Futures 2Reportlinker Adds Renal Cell Carcimona Cancer Drug Futures 3Reportlinker Adds Renal Cell Carcimona Cancer Drug Futures 4Reportlinker Adds Renal Cell Carcimona Cancer Drug Futures 5Reportlinker Adds Renal Cell Carcimona Cancer Drug Futures 6Reportlinker Adds Renal Cell Carcimona Cancer Drug Futures 7Reportlinker Adds Renal Cell Carcimona Cancer Drug Futures 8Reportlinker Adds Renal Cell Carcimona Cancer Drug Futures 9
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: